EMFAT
Emerald Mutual Fund Advisers Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-832
| Closed | -$121K | – | 235 |
|
|
2020
Q3 | $121K | Sell |
832
-15
| -2% | -$2.18K | 0.01% | 254 |
|
|
2020
Q2 | $125K | Buy |
+847
| New | +$125K | 0.01% | 248 |
|
|
2020
Q1 | – | Sell |
-1,002
| Closed | -$115K | – | 224 |
|
|
2019
Q4 | $115K | Buy |
+1,002
| New | +$115K | ﹤0.01% | 219 |
|
|
2015
Q2 | – | Sell |
-3,964
| Closed | -$415K | – | 256 |
|
|
2015
Q1 | $415K | Sell |
3,964
-162,404
| -98% | -$17M | 0.03% | 198 |
|
|
2014
Q4 | $16.1M | Sell |
166,368
-45,319
| -21% | -$4.4M | 1.4% | 13 |
|
|
2014
Q3 | $16.5M | Sell |
211,687
-10,914
| -5% | -$852K | 1.58% | 8 |
|
|
2014
Q2 | $14.1M | Buy |
222,601
+9,640
| +5% | +$609K | 1.29% | 16 |
|
|
2014
Q1 | $14.3M | Sell |
212,961
-141,711
| -40% | -$9.51M | 1.37% | 11 |
|
|
2013
Q4 | $26.4M | Buy |
354,672
+124,595
| +54% | +$9.26M | 1.57% | 9 |
|
|
2013
Q3 | $14.7M | Buy |
230,077
+15,440
| +7% | +$988K | 2.03% | 4 |
|
|
2013
Q2 | $6.65M | Buy |
+214,637
| New | +$6.65M | 1.13% | 28 |
|